Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

A Korean baby with nevus sebaceus syndrome was found to have a KRAS gene mutation.

Certain VDR gene changes can affect melanoma risk.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

VEGF gel increases hair growth but may have potential toxicity.

Five FDA-approved drugs may help block COVID-19 virus entry.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Reducing gefitinib dosage improved hair loss, but scarring remained.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Upadacitinib effectively treats severe alopecia areata and is safe.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Indinavir and ritonavir therapy can cause reversible hair loss.